Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 17, 2011

Primary Completion Date

February 20, 2015

Study Completion Date

February 20, 2015

Conditions
Traumatic Brain Injury
Interventions
DRUG

Glyburide

Administered as specified in the Treatment Arm.

DRUG

Placebo

Administered as specified in the Treatment Arm.

Trial Locations (4)

15213

UPMC Presbyterian Hospital, Pittsburgh

21201

University of Maryland Medical Center, Shock Trauma Center, Baltimore

23298

VCU Medical Center, Richmond

92103

University of California, San Diego, San Diego

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

collaborator

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium

OTHER

lead

Remedy Pharmaceuticals, Inc.

INDUSTRY

NCT01454154 - Glyburide (RP-1127) for Traumatic Brain Injury (TBI) | Biotech Hunter | Biotech Hunter